KWM
RMD icon

Kolinsky Wealth Management’s ResMed RMD Stock Holding History

Kolinsky Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-957
Closed -$232K – 144
2022
Q1 		$232K Sell
957
-70
-7% -$16.9K 0.23% 115
2021
Q4 		$268K Buy
+1,027
New +$266K 0.25% 109

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Kolinsky Wealth Management's RMD Position: Q2 2022 in Review

Kolinsky Wealth Management sold out of ResMed (RMD) in Q2 2022, closing a stake of 957 shares — an estimated $232K sold.

Kolinsky Wealth Management first reported a position in RMD in Q4 2021 and held it in 2 quarters. The position peaked at $268K in Q4 2021. 677 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Kolinsky Wealth Management reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Kolinsky Wealth Management sold 957 ResMed shares in Q2 2022, an estimated $232K.
  • Kolinsky Wealth Management first reported a position in ResMed in Q4 2021 and held it in 2 quarters.
  • Kolinsky Wealth Management's ResMed position peaked at $268K in Q4 2021.
  • 677 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Kolinsky Wealth Management's 13F filing for Q2 2022, filed 15 Aug 2022.